ADMA Biologics ADMA Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $138.15M+57.7% | $87.63M+42.8% | $61.39M-32.0% | $90.29M+26.1% | $71.63M-30.6% | ||
| $135.86M-14.2% | $158.43M+15.1% | $137.67M+25.5% | $109.73M+10.4% | $99.41M+98.8% | ||
| $222.1M+7.6% | $206.47M+5.0% | $196.67M+2.7% | $191.46M+11.2% | $172.19M+1.1% | ||
| $511.17M+9.6% | $466.51M+15.9% | $402.66M+0.8% | $399.56M+13.6% | $351.81M+6.2% | ||
| $65.01M-0.1% | $65.06M-6.4% | $69.51M+20.9% | $57.5M-0.4% | $57.71M+5.5% | ||
| $3.53M0.0% | $3.53M0.0% | $3.53M0.0% | $3.53M0.0% | $3.53M0.0% | ||
| $630K-0.3% | $632K+28.7% | $491K-6.8% | $527K+16.6% | $452K-1.7% | ||
| $665.18M+6.6% | $624.24M+9.8% | $568.69M+1.8% | $558.38M+9.4% | $510.57M+4.5% | ||
| $20.52M-8.9% | $22.52M-6.3% | $24.02M-19.3% | $29.77M+44.5% | $20.61M+1.9% | ||
| $1.37M-2.6% | $1.41M-2.4% | $1.44M+907% | $143K0.0% | $143K0.0% | ||
| $3.28M+16.6% | $2.81M+20.0% | $2.34M— | —— | —— | ||
| $73.54M+5.8% | $69.54M+23.1% | $56.49M-24.6% | $74.94M+40.1% | $53.5M-3.7% | ||
| $193.58M+179% | $69.33M-1.1% | $70.08M— | —— | —— | ||
| $274.86M+87.1% | $146.92M+6.9% | $137.5M-14.1% | $160.06M+16.7% | $137.15M-1.8% | ||
| 300M0.0% | 300M0.0% | 300M0.0% | 300M0.0% | 300M0.0% | ||
| -$116.33M+28.0% | -$161.65M+23.4% | -$211.03M+14.7% | -$247.46M+12.1% | -$281.68M+8.7% | ||
| $390.33M-18.2% | $477.32M+10.7% | $431.19M+8.2% | $398.33M+6.7% | $373.42M+7.0% | ||
| $665.18M+6.6% | $624.24M+9.8% | $568.69M+1.8% | $558.38M+9.4% | $510.57M+4.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are ADMA Biologics's total assets?
- ADMA Biologics (ADMA) holds $665.2M in total assets, up 30.3% year over year.
- How much debt does ADMA Biologics have?
- ADMA Biologics carries $204.4M in total debt against $390.3M of shareholders' equity, a debt-to-equity ratio of 0.52.
- How much cash does ADMA Biologics have?
- ADMA Biologics holds $138.2M in cash and equivalents.
- Can ADMA Biologics cover its short-term obligations?
- Its current ratio is 6.95 — current assets exceed current liabilities.
- Where does ADMA Biologics's balance sheet data come from?
- Every line is extracted from ADMA Biologics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
